e-learning
resources
Stockholm 2002
Tuesday 17.09.2002
Community- and hospital-acquired pneumonias: inflammatory mechanisms, epidemiology and therapy
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Efficacy and safety of Linezolid in pneumonias
A. A. Desai, S. Sinha, P. P. Rao, R. S. Muralidharan, R. Ganesan (Mumbai, Chennai, India)
Source:
Annual Congress 2002 - Community- and hospital-acquired pneumonias: inflammatory mechanisms, epidemiology and therapy
Session:
Community- and hospital-acquired pneumonias: inflammatory mechanisms, epidemiology and therapy
Session type:
Poster Discussion
Number:
2678
Disease area:
Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
A. A. Desai, S. Sinha, P. P. Rao, R. S. Muralidharan, R. Ganesan (Mumbai, Chennai, India). Efficacy and safety of Linezolid in pneumonias. Eur Respir J 2002; 20: Suppl. 38, 2678
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Management of severe community acquired pneumonia – ERS guidelines
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Predictive indexes in prolonged weaning of mechanical ventilation due to tracheostomy in patients with COVID-19 pneumonia
Related content which might interest you:
Efficacy and safety of levofloxacin treatment of community-acquired pneumonia in hospitalized patients
Source: Eur Respir J 2005; 26: Suppl. 49, 637s
Year: 2005
Effectiveness of oral moxifloxacin in standard first-line therapy in community-acquired pneumonia
Source: Eur Respir J 2003; 21: 135-143
Year: 2003
Linezolid: safety and efficacy monitoring
Source: Eur Respir J 2012; 39: 1276-1277
Year: 2012
Linezolid: safety and efficacy monitoring
Source: Eur Respir J 2012; 39: 1275-1276
Year: 2012
Safety and efficacy of CURB65 guided antibiotic therapy in community-acquired pneumonia
Source: Annual Congress 2010 - The prognosis of community-acquired pneumonia: old and new markers of severity
Year: 2010
Efficacy and safety of azithromycin vs. clarithromycin for the treatment of community-acquired pneumonia due to
legionella pneumophila
Source: Annual Congress 2004 - Community acquired pneumonia - epidemiology and host defence
Year: 2004
Efficacy and tolerability of voriconazole in the treatment of pulmonary aspergillosis
Source: Eur Respir J 2007; 30: Suppl. 51, 301s
Year: 2007
Efficacy and safety of stepwise therapy in patients with community-acquired pneumonia
Source: Eur Respir J 2006; 28: Suppl. 50, 377s
Year: 2006
Safety and tolerability of clarithromycin in the treatment of multidrug-resistant tuberculosis
Source: Eur Respir J , 49 (3) 1601612; DOI: 10.1183/13993003.01612-2016
Year: 2017
Efficacy and safety of meropenem–clavulanate added to linezolid-containing regimens in the treatment of MDR-/XDR-TB
Source: Eur Respir J 2013; 41: 1386-1392
Year: 2013
Efficacy and tolerability of linezolid in multidrug-resistant tuberculosis (MDR/XDR-TB)
Source: Annual Congress 2008 - The challenge of multidrug-resistant tuberculosis
Year: 2008
On linezolid efficacy and tolerability
Source: Eur Respir J 2012; 39: 770-772
Year: 2012
Efficacy and safety of chemotherapy regimens containing fluoroquinolones in pediatric TB
Source: Virtual Congress 2021 – Epidemiology and burden of tuberculosis and other lung diseases
Year: 2021
Efficacy, safety and tolerability of linezolid for the treatment of XDR-TB: a study in China
Source: Eur Respir J 2016; 47:1591-1592
Year: 2016
Efficacy, safety and tolerability of linezolid for the treatment of XDR-TB: a study in China
Source: Eur Respir J 2015; 45: 161-170
Year: 2015
Clinical efficacy and safety of micafungin in patients with pulmonary aspergillosis
Source: Eur Respir J 2006; 28: Suppl. 50, 788s
Year: 2006
Pulmonary aspergillosis during pregnancy: tolerability and safety of terbinafine
Source: Eur Respir J 2002; 20: Suppl. 38, 352s
Year: 2002
Cost-effectiveness of full-course oral levofloxacin in severe community-acquired pneumonia
Source: Eur Respir J 2004; 24 : 644-648
Year: 2004
Comparison of conventional and sequential antibiotic therapy of community-acquired pneumonia with levofloxacin and moxifloxacin
Source: Annual Congress 2007 - Antibiotic treatment in community-acquired pneumonia
Year: 2007
Linezolid safety, tolerability and efficacy to treat multidrug- and extensively drug-resistant tuberculosis
Source: Eur Respir J 2011; 38: 730-733
Year: 2011
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept